Menthol 1.25%
Generic Name: menthol 1.25%
Brand Names:
Flexigen
Pain Relieving Cream
Overview
Pain Relieving Cream
Uses
For the temporary relief of minor aches and pain associated with arthritis, simple backache, muscle strains, sprains, and bruises.
Dosage
Adults and children 12 years of age and older, apply to the affected area not more than 3 to 4 times daily. Children under 12 years of age: ask a doctor.
Warnings
For external use only. Do not use with other topical pain relievers, with heating pads or heating devices. When using this product do not use in or near the eyes, do not apply to wounds or damaged skin, do not bandage tightly. Stop use and ask a doctor if condition worsens, if symptoms persist for more than 7 days or clear up and occur again within a few days.
Pregnancy
If pregnant or breast-feeding, ask a health professional before use.
Frequently Asked Questions
What is Menthol 1.25% used for?▼
For the temporary relief of minor aches and pain associated with arthritis, simple backache, muscle strains, sprains, and bruises.
Can I take Menthol 1.25% during pregnancy?▼
If pregnant or breast-feeding, ask a health professional before use.
What are the important warnings for Menthol 1.25%?▼
For external use only. Do not use with other topical pain relievers, with heating pads or heating devices. When using this product do not use in or near the eyes, do not apply to wounds or damaged skin, do not bandage tightly. Stop use and ask a doctor if condition worsens, if symptoms persist for more than 7 days or clear up and occur again within a few days.
Related Medications
Dispersion Of Zinc Oxdie
dispersion of zinc oxdie
Dosage form: LIQUID. Active ingredients: ZINC OXIDE (17.25 kg/25kg). Category: DRUG FOR FURTHER PROCESSING.
Amlodipine Besylate And Benazepril Hydrochloride
amlodipine besylate and benazepril hydrochloride
Amlodipine besylate and benazepril hydrochloride capsules are a combination antihypertensive available in six strengths (2.5/10, 5/10, 5/20, 5/40, 10/20, 10/40 mg) for oral administration.
Tralokinumab-ldrm
tralokinumab-ldrm
Interleukin-13 Antagonist [EPC]
11 DESCRIPTION Tralokinumab-ldrm, an interleukin-13 antagonist, is a human IgG4 monoclonal antibody. Tralokinumab-ldrm is produced in mouse myeloma cells by recombinant DNA technology, consists of 1326 amino acids, and has a molecular weight of approximately 147 kilodaltons.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.